---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-023301"
form_type: "8-K"
ticker: null
cik: "0001138978"
company_name: "Novo Integrated Sciences, Inc."
filed_at: "2023-07-03T23:59:59+00:00"
generated_at: "2026-06-13T13:06:56.471262+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Novo Integrated Sciences CFO Jim Zsebok resigns; receives 1,335,000 shares as settlement

## Summary
- Jim Zsebok resigned as principal financial officer effective June 28, 2023.
- Company issued 1,000,000 registered shares and 335,000 unregistered shares to RTZ Consulting in full satisfaction of obligations.
- Separation agreement includes mutual release of claims, confidentiality, and non-disparagement provisions.

## SEC filing metadata
- accession: 0001493152-23-023301
- form_type: 8-K
- cik: 0001138978
- company_name: Novo Integrated Sciences, Inc.
- filed_at: 2023-07-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1138978/000149315223023301/0001493152-23-023301-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1138978/000149315223023301/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-023301
- JSON: https://secwatch.observer/filing/0001493152-23-023301.json
- Plain text: https://secwatch.observer/filing/0001493152-23-023301.txt

## Key facts
- Executive change
  Jim Zsebok resigned as principal financial officer at Novo Integrated Sciences, Inc..
  - Action: resigned
  - Role: principal financial officer
  source text: Zsebok resigned from the position of principal financial officer with respect to the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1138978/000149315223023301/0001493152-23-023301-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.